Seed Oils and Cancer: What the 2025 Research Actually Shows

In April 2025, a study published in the journal Science by researchers at Weill Cornell Medicine found that linoleic acid — the primary fatty acid in most seed oils — promoted the growth of triple-negative breast cancer (TNBC) tumours in laboratory and mouse models. The study received widespread media coverage and was cited by public figures including Robert F. Kennedy Jr. as evidence that seed oils are "poisoning Americans."

This article looks at what the research actually found, where the evidence is strong, and where significant gaps remain before translating these findings into dietary recommendations.

What the Weill Cornell Study Found

The study, published in Science in March 2025, identified a specific mechanism by which linoleic acid (LA) may promote cancer growth:

1. Linoleic acid binds to a protein called FABP5 (fatty acid binding protein 5), which is highly expressed in triple-negative breast cancer cells
2. When LA binds to FABP5, it activates signalling pathways that promote cell proliferation and tumour growth
3. In mouse models, diets higher in linoleic acid accelerated TNBC tumour growth; diets lower in linoleic acid slowed it
4. In human patients with TNBC, researchers found higher concentrations of linoleic acid in tumour tissue and blood compared to controls

These findings are scientifically significant. They identify a plausible, specific biological mechanism — not just an association. FABP5 overexpression in TNBC is well-established, and the linoleic acid–FABP5 interaction was rigorously demonstrated.

What the Study Does Not Show

Several important caveats apply before drawing broad conclusions:

It Is Not Evidence That Seed Oils "Cause" Cancer

The study demonstrates that linoleic acid can promote growth of an already-established cancer in a specific subtype (triple-negative). It does not demonstrate that linoleic acid initiates cancer or causes cancer to develop in the first place. These are distinct biological questions.

The Human Cohort Data Is Associational

The finding that TNBC patients had higher linoleic acid in tumours and blood is a cross-sectional association, not a demonstration of causality. TNBC patients may have other dietary patterns that co-vary with linoleic acid levels.

Large Population Studies Show No General Breast Cancer Risk

A 2023 meta-analysis of 14 studies covering over 350,000 women found no significant association between dietary linoleic acid intake and overall breast cancer risk. The Weill Cornell findings relate specifically to TNBC — a subtype accounting for approximately 10–15% of breast cancers.

Mouse Models Have Limitations

The in vivo tumour growth effects were demonstrated in mice. The dietary linoleic acid doses used in some mouse experiments often exceed what humans consume. Translating mouse diet studies to human outcomes requires significant caution.

The Broader Context: Linoleic Acid and Cancer Research

The Weill Cornell study is not the first to examine the linoleic acid–cancer connection, and the wider literature is mixed:

• A 2025 review in PMC examining historical trends found a statistical correlation between rising linoleic acid consumption (largely from seed oils) and rising cancer rates since the mid-20th century — though correlation and causation are distinct
• Multiple large prospective cohort studies (including the Nurses' Health Study) have found no increased overall cancer risk with higher linoleic acid intake
• Some research has found lower colon and lung cancer risk with higher linoleic acid intake, consistent with its anti-inflammatory effects in those contexts

The picture is genuinely complicated: linoleic acid's effects appear to depend heavily on cancer subtype, the inflammatory microenvironment, FABP5 expression levels, and the overall fatty acid composition of the diet (particularly the omega-6:omega-3 ratio).

The Omega-6:Omega-3 Ratio Dimension

One aspect underemphasised in most media coverage is that the Weill Cornell findings are most relevant in the context of a high omega-6 diet with low omega-3.

EPA and DHA (omega-3 fatty acids from oily fish) are known to have anti-proliferative and pro-apoptotic effects in multiple cancer types. They compete with linoleic acid and arachidonic acid at the same metabolic pathways. A diet high in omega-6 and low in omega-3 creates a cellular environment that may amplify the linoleic acid effects the Weill Cornell study identified.

A diet with a balanced omega-6:omega-3 ratio — achieved either by reducing seed oil consumption or by increasing oily fish and omega-3 supplementation — may substantially modulate any linoleic acid risk from this mechanism.

Vitabiotics Ultra Omega-3 1000mg — increasing EPA and DHA intake directly counteracts the omega-6 dominance that underlies the pro-inflammatory and potentially pro-tumour signalling discussed above.

What Researchers Are Recommending

The lead researchers at Weill Cornell noted that their findings do not support wholesale avoidance of seed oils, but do support:

1. Awareness that very high linoleic acid intake in the context of an existing TNBC diagnosis may affect tumour behaviour
2. Further investigation into dietary linoleic acid as a modifiable factor in TNBC management
3. The importance of the omega-6:omega-3 ratio in cancer biology research

The study authors did not call for people to eliminate linoleic acid from their diets. They called for more research into dietary fat composition and cancer subtype-specific risk.

Practical Interpretation

For the general population, the 2025 Weill Cornell findings do not justify panic about seed oils and cancer based on current evidence. The mechanism is real and worth monitoring as research develops, but it:

• Applies specifically to TNBC, not cancer broadly
• Has not been demonstrated in human dietary intervention trials
• Does not show that linoleic acid causes cancer to develop
• Does not account for confounding dietary factors

For people with TNBC or a family history of hormone-receptor-negative breast cancer, the Weill Cornell findings may be worth discussing with an oncologist in the context of overall dietary planning — including the role of omega-3 supplementation and seed oil reduction.

For the broader population, the more established case for reducing seed oil consumption rests on chronic inflammation, cardiovascular risk, and the omega-6:omega-3 ratio — not this specific cancer mechanism.

Affiliate disclosure: We earn a small commission from qualifying Amazon purchases at no extra cost to you.